Table 1.
Patient characteristics and treatment outcomes
| Patient No. | Age (years) | Gender | ECOG PS score | Primary tumour site | Histology differentiation | No. of organ involved | Prior treatment | Response | PFS (months) | OS (months) | Disease status |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 80 | Male | 3 | EGJ | poor | 2 | Untreated | PR | 7.1 | 15.4 | Dead of disease |
| 2 | 63 | Female | 3 | antrum | poor | 3 | Untreated | PR | 7.7 | 10.7 | Alive with disease |
| 3 | 41 | Female | 3 | antrum | poor | 2 | Surgery alone | PR | 8.0 | 9.0 | Alive with disease |
| 4 | 44 | Female | 3 | EGJ | poor | 2 | Adjuvant chemo | SD | 6.5 | 9.2 | Dead of disease |
| 5 | 39 | Female | 3 | body | poor | 2 | Surgery alone | NA | 1.7 | 3.1 | Dead of disease |
| 6 | 47 | Female | 3 | body | poor | 3 | Adjuvant chemo | PD | 2.2 | 4.5 | Alive with disease |
| 7 | 43 | Female | 4 | body | poor | 3 | Untreated | PR | 11.7 | 13.0 | Alive with disease |
| 8 | 55 | Male | 4 | EGJ | poor | 3 | Surgery alone | PR | 10.4 | 11.4 | Alive with disease |
| 9 | 46 | Female | 3 | body | poor | 3 | Untreated | PR | 6.9 | 7.2 | Alive with disease |
| 10 | 74 | Male | 4 | antrum | poor | 4 | Untreated | PR | 7.5 | 8.5 | Alive with disease |
| 11 | 48 | Female | 3 | antrum | poor | 2 | Untreated | PR | 4.5 | 6.8 | Dead of disease |
| 12 | 42 | Female | 4 | body | poor | 3 | Untreated | PR | 4.0 | 9.8 | Dead of disease |
Chemo = chemotherapy, ECOG = Eastern Cooperative Oncology Group, EGJ = oesophago-gastric junction, OS: overall survival, PD = progressive disease, PFS = progression-free survival, PR = partial response, PS = performance status, SD = stable disease.